Hsbc Holdings PLC Provention Bio, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$6.7 - $24.21 $4.72 Million - $17.1 Million
704,537 New
704,537 $17 Million
Q4 2021

Feb 11, 2022
SELL
$5.59 - $7.39 $130,537 - $172,571
-23,352 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.66 - $8.33 $58,779 - $86,507
10,385 Added 80.09%
23,352 $150,000
Q2 2021

Aug 13, 2021
BUY
$6.71 - $11.04 $16,607 - $27,323
2,475 Added 23.59%
12,967 $109,000
Q1 2021

May 14, 2021
BUY
$10.12 - $19.45 $106,179 - $204,069
10,492 New
10,492 $110,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email